Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	330.70	-197.88	45.95
Graham Fair Price	31.16	9.32	7.10
PEG	-51.20	0.16	-0.33
Price/Book	8.15	1.03	0.95
Price/Cash Flow	90.09	41.78	21.98
Prices/Earnings	-37.38	11.87	18.95
Price/Sales	-32.47	7.00	10.36
Price/FCF	90.09	41.78	21.98
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	0.81	1.01	1.00
Operating Margin	76.99	0.21	0.12
ROA	68.73	< 0.005	< 0.005
ROE	0.01	0.02	72.70
ROIC	< 0.005	0.01	116.29
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.22	-0.08	163.72
Dividends QOQ	< 0.005	< 0.005	45.17
EBIT QOQ	-0.70	1.83	162.05
EPS QOQ	-0.57	0.73	28.33
FCF QOQ	-0.14	-0.43	-205.52
Revenue QOQ	-0.05	0.60	1035.66
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	33014.35	100.00
Days Sales Outstanding (DSO)	345.52	229.45	-33.59
Inventory Turnover	0.00	< 0.005	100.00
Debt/Capitalization	0.39	0.44	12.25
Quick Ratio	33.10	0.21	-99.36
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	13.37	13.34	-0.19
Cash	9.46	12.07	27.65
Capex	-0.04	-0.02	46.68
Free Cash Flow	0.58	0.33	-43.22
Revenue	1.23	1.96	59.84
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	43.33	0.11	-99.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	4.65	-23.43	404.09
Naive Interpretation	Member

06 - Financial Health · Bad

Rating